The current status of stem cell-based therapies during ex vivo graft perfusion: An integrated review of four organs-Reference-Cited by-同舟云学术

The current status of stem cell-based therapies during ex vivo graft perfusion: An integrated review of four organs

Published:2022-12 Issue:12 Volume:22 Page:2723-2739
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Luijmes Stefan H.^ORCID,Verstegen Monique M.A.^ORCID,Hoogduijn Martin J.^ORCID,Seghers Leonard^ORCID,Minnee Robert C.^ORCID,Mahtab Edris A.F.^ORCID,Taverne Yannick J.H.J.^ORCID,Reinders Marlies E.J.^ORCID,van der Laan Luc J.W.^ORCID,de Jonge Jeroen^ORCID

Funder

Medical Delta

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.17161

Reference40 articles.

1. Survival following liver transplantation from non-heart-beating donors;Abt;Ann Surg.,2004

2. Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation;Locke;Am J Transplant.,2007

3. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives;Liang;Cell Transplant.,2014